Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -206.78% is 74% below its 5-year average of -119.05%, near the low end of its 5-year range (-206.78%–-46.57%).
54.16% below its 12-month average of -134.13%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -51.52%.
RETURN ON ASSETS (ROA)
-206.78%
RETURN ON ASSETS (ROA) AVG TTM
-134.13%
RETURN ON ASSETS (ROA) AVG 3Y
-143.93%
RETURN ON ASSETS (ROA) AVG 5Y
-119.05%
RETURN ON ASSETS (ROA) AVG 10Y
-120.15%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-54.16%
CURRENT VS 3Y AVG
-43.67%
CURRENT VS 5Y AVG
-73.69%
CURRENT VS 10Y AVG
-72.10%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.48%
median of 786 covered companies
CURRENT VS SECTOR MEDIAN
-556.97%
vs the sector median at left
PolyPid Ltd.
Market Cap
$99.61M
Return on Assets (ROA)
-206.78%
TTM Avg
-134.13%
3Y Avg
-143.93%
5Y Avg
-119.05%
Market Cap
$97.61M
Return on Assets (ROA)
-46.26%
TTM Avg
-55.26%
3Y Avg
-67.06%
5Y Avg
-56.22%
Market Cap
$97.49M
Return on Assets (ROA)
-65.25%
TTM Avg
-70.13%
3Y Avg
-63.89%
5Y Avg
-46.24%
Market Cap
$97.00M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$102.25M
Return on Assets (ROA)
-32.73%
TTM Avg
-70.83%
3Y Avg
-106.23%
5Y Avg
-81.00%
Market Cap
$102.67M
Return on Assets (ROA)
7.36%
TTM Avg
-1.10%
3Y Avg
-3.18%
5Y Avg
2.66%
Market Cap
$104.68M
Return on Assets (ROA)
-57.98%
TTM Avg
-386.38%
3Y Avg
-312.00%
5Y Avg
-312.00%
Market Cap
$104.96M
Return on Assets (ROA)
-69.14%
TTM Avg
-63.05%
3Y Avg
-52.31%
5Y Avg
-58.69%
Market Cap
$105.13M
Return on Assets (ROA)
-33.85%
TTM Avg
-28.41%
3Y Avg
-17.06%
5Y Avg
-12.28%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PolyPid Ltd. (PYPD) | $99.61M | -206.78% | -134.13% | -143.93% | -119.05% |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $97.61M | -46.26% | -55.26% | -67.06% | -56.22% |
| Korro Bio, Inc. (KRRO)vs › | $97.49M | -65.25% | -70.13% | -63.89% | -46.24% |
| Conexeu Sciences Inc. (CNXU)vs › | $97.00M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.25M | -32.73% | -70.83% | -106.23% | -81.00% |
| The Joint Corp. (JYNT)vs › | $102.67M | 7.36% | -1.10% | -3.18% | 2.66% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | -57.98% | -386.38% | -312.00% | -312.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.96M | -69.14% | -63.05% | -52.31% | -58.69% |
| Definitive Healthcare Corp. (DH)vs › | $105.13M | -33.85% | -28.41% | -17.06% | -12.28% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.48M | -1.90% | 1.32% | 1.93% | 1.93% |
ROA
-206.8%
ROE
-584.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -153.18% |
| 2024-12-31 | -115.08% |
| 2023-12-31 | -155.25% |
| 2022-12-31 | -152.19% |
| 2021-12-31 | -92.04% |
| 2020-12-31 | -46.57% |
| 2019-12-31 | -20.45% |
| 2018-12-31 | 40.85% |
| 2017-12-31 | -237.07% |
| 2016-12-31 | -59.22% |
| 2015-12-31 | -331.45% |
| 2013-12-31 | -198.26% |
| 2012-12-31 | -115.56% |
